Literature DB >> 29414124

A novel unit-dose approach for the pharmaceutical compounding of an orodispersible film.

Wen Chin Foo1, Yuet Mei Khong2, Rajeev Gokhale3, Sui Yung Chan4.   

Abstract

Orodispersible films (ODF) have clinical potential as extemporaneous pharmacy preparations for individualized pharmacotherapy. However, the conventional method of ODF preparation using a film applicator may limit its application, due to content uniformity challenges arising from viscosity changes of the casting solution and varied operator manipulation. This study proposes the unit-dose (UD) plate as an alternative to the film applicator for compounding individual ODFs. Using a design-of-experiments approach, we developed an extemporaneous ODF formulation for an antiemetic drug, ondansetron hydrochloride dihydrate (OND), at a clinically relevant dose. ODFs cast with the UD plate showed excellent content uniformity independent of the viscosity of the casting solution and drug concentration. Formulations were evaluated for performance with respect to patient acceptability and product quality. The effects of critical process parameters on critical quality attributes of the ODF were studied. HPMC concentration and volume of casting solution were the main factors affecting disintegration time and mechanical properties of the film, while drug concentration had no significant effect. However, further studies incorporating different drugs in larger concentration ranges are needed to investigate the impact of drug concentration and to establish a design space. Nevertheless, our results indicate the potential of using the UD plate to prepare ODFs with customized drug doses from a generic casting solution. Results from this study provide a framework for an extemporaneous ODF platform.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Extemporaneous preparation; Non-sterile compounding; Ondansetron hydrochloride; Orodispersible film; Solvent-casting; Unit-dose plate

Mesh:

Substances:

Year:  2018        PMID: 29414124     DOI: 10.1016/j.ijpharm.2018.01.047

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  5 in total

Review 1.  Printing Methods in the Production of Orodispersible Films.

Authors:  Maram Suresh Gupta; Tegginamath Pramod Kumar; Robert Davidson; Guruprasad Rao Kuppu; Kamla Pathak; Devegowda Vishakante Gowda
Journal:  AAPS PharmSciTech       Date:  2021-04-09       Impact factor: 3.246

2.  Effects of Various Drying Times on the Properties of 3D Printed Orodispersible Films.

Authors:  Natália Janigová; Jan Elbl; Sylvie Pavloková; Jan Gajdziok
Journal:  Pharmaceutics       Date:  2022-01-21       Impact factor: 6.321

Review 3.  A Comprehensive Review of Patented Technologies to Fabricate Orodispersible Films: Proof of Patent Analysis (2000-2020).

Authors:  Maram Suresh Gupta; Devegowda Vishakante Gowda; Tegginamath Pramod Kumar; Jessica M Rosenholm
Journal:  Pharmaceutics       Date:  2022-04-08       Impact factor: 6.525

Review 4.  Quality of FDM 3D Printed Medicines for Pediatrics: Considerations for Formulation Development, Filament Extrusion, Printing Process and Printer Design.

Authors:  Julian Quodbach; Malte Bogdahn; Jörg Breitkreutz; Rebecca Chamberlain; Karin Eggenreich; Alessandro Giuseppe Elia; Nadine Gottschalk; Gesine Gunkel-Grabole; Lena Hoffmann; Dnyaneshwar Kapote; Thomas Kipping; Stefan Klinken; Fabian Loose; Tristan Marquetant; Hellen Windolf; Simon Geißler; Tilmann Spitz
Journal:  Ther Innov Regul Sci       Date:  2021-11-26       Impact factor: 1.337

5.  Physiologically Based Pharmacokinetic Modeling to Understand the Absorption of Risperidone Orodispersible Film.

Authors:  Fang Chen; Hongrui Liu; Bing Wang; Liuliu Yang; Weimin Cai; Zheng Jiao; Zhou Yang; Yusheng Chen; Yingjun Quan; Xiaoqiang Xiang; Hao Wang
Journal:  Front Pharmacol       Date:  2020-02-03       Impact factor: 5.810

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.